I wonder why there is so much hype around the Canadian pot company Aurora Cannabis (NYSE: ACB) when it has time and again failed to meet investors’ expectations.

Aurora Cannabis might be a popular pot stock among investors, but if you look around, U.S. cannabis stocks hold much greater potential. One such company is Massachusetts-based Curaleaf Holdings (OTC: CURLF). While most of the Canadian players continued struggling in 2020, Curaleaf had a spectacular year. Aurora’s stock dipped 60% over the past year, while Curaleaf’s stock has soared 103%. Meanwhile, the industry benchmark, the Horizons Marijuana Life Sciences ETF, is down 4% over the same period.

Curaleaf’s revenue grew threefold in all of its quarters this year along with consistent positive earnings before income, taxes, depreciation, and amortization (EBITDA). The company claims to be the largest cannabis company in the U.S., which is evident from its market presence in 23 states. Let’s take a look at its progress this year and why it could be a better pick for investors eyeing some long-term gains. [Read more at Nasdaq]